|News & Information for December 6, 2018
Too Much Sleep Increases Risk of Death, Cardiovascular Disease
A study published Wednesday found that people who slept for more than the recommended six to eight hours per day – including daytime naps – had an increased risk of dying and developing cardiovascular disease. It was discovered that too much sleep can seriously impact someone’s health, including developing diseases of the heart or blood vessels in the brain. Published in the European Heart Journal, the study observed 116,632 people aged 35 to 70 from 21 countries over nearly eight years. Researchers found that people who slept for eight to nine hours per day had a 5 percent increased risk of developing harmful health conditions compared to people who slept for the recommended six to eight hours.
Research shows impact of school start times on teens’ sleep
Delaying high school start times by as little as 10 minutes can increase adolescents’ length of sleep by almost 25 minutes, says new Brock-led research. Similarly, shifts to earlier start times for secondary school were associated with less sleep among the students, says the study, “School start time changes in the COMPASS study: associations with youth sleep duration, physical activity, and screen time.” Lead author, Brock Assistant Professor of Health Sciences Karen Patte, says the results are significant because at least one-third of adolescents don’t get the recommended eight to 10 hours of sleep. “Sleep deficiency increases the risk of various health concerns and risk behaviours, such as substance use, lower academic achievement, poor mental health, accidents and injuries, obesity and unhealthy eating habits,” says Patte.
The discrepancy in recommended sleep times in the above two studies is due to youth vs adult recommendations. Teens are recommended to sleep 8 to 10 hours whereas 7 to 9 hours are recommended for adults (see).
Why You Should Avoid Social Media After a Failure
When Nava failed the bar exam for lawyers she was devastated. Trying to delay telling her friends and family the bad news she did what she often did to pass the time: She pulled out her phone and surfed through friends’ Facebook and Instagram feeds. […] But the more time Nava spent looking through her friends’ posts the worse her mood became. And then something happened that happens to many of us: She began to feel bad about the fact that she was feeling bad. […] The question is, why did seeing friends’ Facebook and Instagram posts, many of which were inspirational and supportive in nature, make Nava feel worse about her failure? […] When our negative feelings are not validated by others, or when, like Nava and the participants in the study, we see around us messages that imply it is wrong or incorrect to have negative feelings, we are likely to experience the double whammy of feeling bad about the failure and then feeling bad about ourselves for feeling bad.
UK: Rising teen antidepressant use in Tayside as mental health charity warns more young people reaching crisis
Figures obtained via a Freedom of Information request reveal prescriptions of antidepressant drugs to youngsters aged 10-17 in the region increased by 15% last year, with the largest number handed out to those aged 13 and older. The sharpest rise was seen among 17-year-olds, where prescriptions increased from 289 in 2016/17 to 367 in 2017/18. Children as young as five, and at least four under the age of 10, were also given the drugs last year. NHS Tayside stressed the number of prescribed antidepressants should not be used to infer a rise in the number of patients with depression. The health authority said the medication can be used for a wide range of conditions, including pain and bedwetting.
This Company Treats “ADHD” With Video Games
Digital therapeutics delivers real treatment to patients through phones and tablets. At Akili Interactive, medicine comes in the form of a game. Akili Interactive has created the medical equivalent of nutritious snack cakes. The company, based in Boston and San Francisco, develops video games that deliver sensory and motor stimuli engineered to treat conditions like ADHD, autism, depression, and MS. When Akili’s first product comes to market following FDA approval, possibly by next year, doctors will prescribe it like medicine. But it is medicine that has no serious side effects, adapts to patients’ functioning in real time, and is a pleasure to take. “That is not something that was in the world before,” founder and CEO Eddie Martucci says.